Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 3, 2023 OWNERSHIP DOCUMENT
4 Sep 28, 2023 OWNERSHIP DOCUMENT
4 Sep 25, 2023 4
SC 13D Sep 21, 2023 SC 13D
SC 13D Sep 21, 2023 SC 13D
4 Sep 21, 2023 FORM 4 SUBMISSION
SC 13G Sep 21, 2023 SC 13G
SC 13G Sep 21, 2023 SC 13G
8-K/A Sep 21, 2023 8-K/A
SC 13D/A Sep 15, 2023 SC 13D/A
4 Sep 13, 2023 4
3 Sep 13, 2023 3
4 Sep 13, 2023 FORM 4 SUBMISSION
4 Sep 13, 2023 4
4 Sep 13, 2023 FORM 4 SUBMISSION
4 Sep 13, 2023 FORM 4 SUBMISSION
4 Sep 13, 2023 FORM 4 SUBMISSION
4 Sep 13, 2023 FORM 4 SUBMISSION
3 Sep 13, 2023 3
3 Sep 13, 2023 FORM 3 SUBMISSION
3 Sep 13, 2023 FORM 3 SUBMISSION
3 Sep 13, 2023 FORM 3 SUBMISSION
3 Sep 13, 2023 FORM 3 SUBMISSION
3 Sep 13, 2023 FORM 3 SUBMISSION
3 Sep 13, 2023 FORM 3 SUBMISSION
← Newer Page 11 of 27 · 661 filings Older →